Hutch News

Hutch News

Stories tagged 'biostatistics'

Finasteride can reduce prostate cancer risk long term

Fred Hutch study taps big data to tease out extended cancer-prevention benefit of drug used for enlarged prostate, hair loss

March 21, 2018 | By Diane Mapes / Fred Hutch News Service

Fred Hutch public health researcher Dr. Joe Unger used an innovative trial design to confirm finasteride, a drug used to treat enlarged prostate or hair loss in men, has a long-term protective effect against prostate cancer.

View story >

Childhood cancer survivors pay more for health care, more likely to be denied insurance coverage

Adult survivors of childhood cancer suffer from ‘financial toxicity’ decades later, a study conducted at the dawn of the Affordable Care Act found

Sept. 26, 2017 | By Rachel Tompa / Fred Hutch News Service

Before the Affordable Care Act's rollout, adult survivors of childhood cancer were more likely to be denied health care coverage than those without a history of cancer, paid more out-of-pocket and were more likely to borrow money to pay their medical bills, a new study has found.

View story >

Good News at Fred Hutch

Celebrating faculty and staff achievements

July 20, 2017

CBS'Sunday Morning" features Dr. Jim Olson's tumor paint research, Hutch researchers received HIV cure research grants to investigate approaches to overcoming the main barrier to an HIV cure: reducing reservoirs of virus that lie dormant in some of the longest-lived cells of the body.grants.

View story >

Chance of surviving childhood cancer has improved — but survivors’ overall health has not

In large study of childhood cancer survivors, self-reported health remained constant or declined for patients treated in recent decades

Nov. 7, 2016 | By Rachel Tompa / Fred Hutch News Service

Survival of childhood cancers is higher in recent decades. But a new study shows that survivors' overall self-reported health has not improved in tandem.

View story >

Common genetic disorder linked to increased death rate from cancer drug

Researchers recommend ‘caution’ when using the chemotherapy busulfan in patients with Gilbert’s syndrome

Oct. 27, 2016 | By Susan Keown / Fred Hutch News Service

As many as one of every 10 people has Gilbert's syndrome, which is typically benign and has even been linked to long life. But new research suggests that busulfan, a bone marrow transplant drug, is extra risky in people with the condition.

View story >

Low-fat diet reduces risk of breast cancer and subsequent death

Women’s Health Initiative study indicates benefit to low-fat, fruit and veggie-rich diet

April 18, 2016 | By Sabrina Richards / Fred Hutch News Service

Women’s Health Initiative study indicates benefit to low-fat, fruit and veggie-rich diet

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.